Literature DB >> 25184861

Sham controls in medical device trials.

Rita F Redberg1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25184861     DOI： 10.1056/NEJMp1406388

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

1.  How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?

Authors:  Andre M Samuel; Vinay K Rathi; Jonathan N Grauer; Joseph S Ross
Journal:  Clin Orthop Relat Res       Date:  2015-11-19       Impact factor: 4.176

2.  Hard-Wired Bias: How Even Double-Blind, Randomized Controlled Trials Can Be Skewed From the Start.

Authors:  Vinay Prasad; Vance W Berger
Journal:  Mayo Clin Proc       Date:  2015-08-12       Impact factor: 7.616

Review 3.  Device-Based Therapy for Drug-Resistant Hypertension: An Update.

Authors:  Ping Li; Mark Nader; Kousalya Arunagiri; Vasilios Papademetriou
Journal:  Curr Hypertens Rep       Date:  2016-08       Impact factor: 5.369

4.  Research Needs and Priorities for Catheter Ablation of Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop.

Authors:  Sana M Al-Khatib; Emelia J Benjamin; Alfred E Buxton; Hugh Calkins; Mina K Chung; Anne B Curtis; Patrice Desvigne-Nickens; Pierre Jais; Douglas L Packer; Jonathan P Piccini; Yves Rosenberg; Andrea M Russo; Paul J Wang; Lawton S Cooper; Alan S Go
Journal:  Circulation       Date:  2019-11-20       Impact factor: 29.690

5. 

Authors:  Harrison N Jones; Maragatha Kuchibhatla; Kelly D Crisp; Lisa D Hobson Webb; Laura Case; Milisa T Batten; Jill A Marcus; Richard M Kravitz; Priya S Kishnani
Journal:  Mol Genet Metab       Date:  2019-05-08       Impact factor: 4.797

Review 6.  Sphincter of Oddi dysfunction Type III: New studies suggest new approaches are needed.

Authors:  C Mel Wilcox
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

7.  Indications for Insulin Pump Therapy in Type 1 Diabetes and Associations With Glycemic Control.

Authors:  Johan H Jendle; Araz Rawshani; Ann-Marie Svensson; Tarik Avdic; Soffia Gudbjörnsdóttir
Journal:  J Diabetes Sci Technol       Date:  2016-08-22

8.  Characteristics of Clinical Studies Used for US Food and Drug Administration Approval of High-Risk Medical Device Supplements.

Authors:  Sarah Y Zheng; Sanket S Dhruva; Rita F Redberg
Journal:  JAMA       Date:  2017-08-15       Impact factor: 56.272

Review 9.  Placebo effects in trials evaluating 12 selected minimally invasive interventions: a systematic review and meta-analysis.

Authors:  Robin Holtedahl; Jens Ivar Brox; Ole Tjomsland
Journal:  BMJ Open       Date:  2015-01-30       Impact factor: 2.692

10.  Is FAME 2 a breakthrough for PCI in stable coronary disease?

Authors:  Udo Sechtem
Journal:  Clin Res Cardiol       Date:  2014-12-06       Impact factor: 5.460
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.